Search Results - "LOBANOK, Tatiana"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis by Walter P Maksymowych, A Robin Poole, Lori Hiebert, Alison Webb, Mirela Ionescu, Tatiana Lobanok, Lindsay King, John C Davis, Jr

    Published in Journal of rheumatology (01-10-2005)
    “…OBJECTIVE: Anti-tumor necrosis factor-alpha (TNF-alpha) therapies are not only beneficial for reducing symptoms in rheumatoid arthritis (RA) but also for…”
    Get full text
    Journal Article
  2. 2

    Associations between joint space narrowing and molecular markers of collagen and proteoglycan turnover in patients with knee osteoarthritis by MAZZUCA, Steven A, POOLE, A. Robin, BRANDT, Kenneth D, KATZ, Barry P, LANE, Kathleen A, LOBANOK, Tatiana

    Published in Journal of rheumatology (01-06-2006)
    “…OBJECTIVE: We examined whether plasma concentrations of biomarkers of the collagenase cleavage of type II collagen (C2C), types I and II collagens (C1,2C),…”
    Get full text
    Journal Article
  3. 3
  4. 4

    The ratio of type II collagen breakdown to synthesis and its relationship with the progression of knee osteoarthritis by Cahue, S., M.P.H, Sharma, L., M.D, Dunlop, D., Ph.D, Ionescu, M., M.Sc, Song, J., M.S, Lobanok, T., M.Sc, King, L., Ph.D, Poole, A. Robin, Ph.D., D.Sc

    Published in Osteoarthritis and cartilage (01-07-2007)
    “…Summary Objective To examine whether the baseline ratio of a type II collagen breakdown marker to a synthesis marker, or the level of these markers…”
    Get full text
    Journal Article
  5. 5

    Cartilage biomarkers in ankylosing spondylitis: Relationship to clinical variables and treatment response by Kim, Tae‐Hwan, Stone, Millicent, Payne, Ursula, Zhang, Xiang, Ionescu, Mirela, Lobanok, Tatiana, King, Lindsay, Poole, A. Robin, Inman, Robert D.

    Published in Arthritis and rheumatism (01-03-2005)
    “…Objective Ankylosing spondylitis (AS) is a progressive disease in which chronic inflammation can lead to extensive new bone formation throughout the spine. At…”
    Get full text
    Journal Article
  6. 6